In Brief
- Maharashtra FDA seized drugs and cosmetics worth ₹34.51 lakh.
- 122 licences were cancelled to curb illegal drug trade.
- FDA urges public to report illegal manufacturing or sale of drugs.
- Reports of substandard drugs, medical devices, and cosmetics can be made to FDA offices.
What happened?
The Maharashtra Food and Drug Administration (FDA) recently seized drugs and cosmetics valued at ₹34.51 lakh and cancelled 122 licences pertaining to their manufacture and sale. The actions aim to strengthen public health safety by tackling illegal manufacturing and distribution of harmful substances.
Background and official response
The FDA has been actively inspecting various establishments to ensure compliance with regulations governing drugs and cosmetics. During these drives, significant quantities of substandard or illegal products were identified and confiscated. Following investigations, licences of non-compliant entities were revoked to prevent further violations.
The FDA has urged citizens to cooperate by reporting any instances of illegal drug manufacturing or sales. They have also been encouraged to report suspected substandard drugs, medical devices, and cosmetics. Such complaints can be lodged at the FDA commissioner’s office or the nearest district FDA office, facilitating timely action against offenders.
Why it matters
These measures are critical in preventing the circulation of unregulated and potentially harmful substances in the market, thereby safeguarding consumer health. By enforcing strict actions, the FDA reinforces regulatory compliance, ensuring only quality products reach consumers. Public participation in reporting suspicious activities supports more effective monitoring and enforcement.
